期刊文献+

三氧化二砷对肺癌移植瘤的放疗增敏效应 被引量:3

Radiosensitization effects of arsenic trioxide in lung cancer xenografts
下载PDF
导出
摘要 目的:探讨三氧化二砷(As_2O_3)对肺癌移植瘤的放疗增敏作用及其可能机制。方法:在C57BL/6小鼠右前肢腋窝皮下接种Lewis肺癌细胞,建立肿瘤小鼠模型。将40只荷瘤小鼠随机分成4组:对照组(腹腔注射生理盐水0.2 ml);单纯照射组(腹腔注射生理盐水0.2 ml,6 MeV电子线照射,10 Gy);As_2O_3组(2.0 mg/kg,溶于0.2 ml生理盐水中,腹腔注射);As_2O_3+照射组(2.0 mg/kg腹腔注射As_2O_3后,6 MeV电子线照射,10 Gy)。实验结束后,处死各组动物,分离肿瘤,称取瘤质量,计算抑瘤率。用RT-PCR法测定肿瘤组织中VEGF和Ku70 mRNA水平,免疫组织化学法测定肿瘤组织中VEGF和Ku70蛋白的表达。结果:成功建立Lewis肺癌荷瘤小鼠模型。与对照组、As_2O_3组及单纯照射组比较,As_2O_3+照射组的抑瘤率明显增高,而VEGF和Ku70 mRNA和蛋白表达均显著下调(P均<0.05)。结论:As_2O_3能增加肺癌移植瘤的放射敏感性,其辐射增敏作用可能与下调照射后肿瘤组织VEGF和Ku70的表达有关。 OBJECTIVE:To explore the effects of arsenic trioxide on radiosensitivity and the possible mechanism in lung cancer xenografts.METHODS:The tumor-bearing C57BL/6 mouse model was established by injecting Lewis lung cancer cells into right infra-axillary dermis.40 mice were randomized into 4 groups:control group(peritoneal injection 0.9%NS,0.2 ml);As_2O_3 group(peritoneal injection,2.0 mg/kg,0.2 ml As_2O_3);irradiation group(peritoneal injection 0.9% NS,0.2 ml + 6MeV Electron Beam,10 Gy);As_2O_3 + irradiation group(peritoneal injection,2.0 mg/kg,0.2 ml As_2O_3 + 6MeV Electron Beam,10 Gy).After experiments,mice were sacrificed,then the tumors were separated and weighed.Response to irradiation was evaluated by tumor-inhibiting rate.The expressions of VEGF and Ku70 mRNA were evaluated by RT—PCR. The protein levels of VEGF and Ku70 were measured by immunohistochemical staining.RESULTS:The Lewis lung cancer-bearing model was successfully established in mice.As_2O_3 + irradiation could significantly increase the tumor-inhibiting rate and downregulate the expression of VEGF and Ku70 of irradiated carcinoma xenografts,(Compared with As_2O_3 group or irradiation group,P0.05).CONCLUSION:Arsenic trioxide could sensitize lung cancer xenografts to ionizing irradiation. This effect was probably mediated by downregulating the expressions of VEGF and Ku70.
出处 《癌变.畸变.突变》 CAS CSCD 2011年第1期22-25,30,共5页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 重庆市卫生局中医药科研计划项目(2008-2-31)
关键词 三氧化二砷 肺癌 放射敏感性 arsenic trioxide lung cancer radiosensitivity
  • 相关文献

参考文献15

  • 1Zhou J,Zhang Y,Li J,et al.Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia[J].Blood,2010,115 (9):1697-1702.
  • 2Gore SD,Gojo I,Sekeres MA,et al.Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia[J].J Clin Oncol,2010,28(6):1047-1053.
  • 3Sumi D,Shinkai Y,Kumagai Y.Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells[J].Toxicol Appl Pharmacol,2010,244 (3):385-392.
  • 4Wu DD,Xiao YF,Geng Y,et al.Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice[J].Cancer Genet Cytogenet,2010,198 (2):90-96.
  • 5Zhang N,Wu ZM,McGowan E,et al.Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells:therapeutic potential for ovarian cancer[J].Cancer Sci,2009,100 (12):2459-2464.
  • 6王钦文,刁鑫伟,陈正堂,叶明福,许建平,王亚丽.血管内皮生长因子和基质金属蛋白酶-9在前列腺癌中的表达及其相互关系[J].第三军医大学学报,2009,31(19):1859-1861. 被引量:5
  • 7Bjork-eriksson T,West C,Nilsson A,et al.The immunohischemical expression of DNA-PKCs and Ku(P70) in head and neck cancer:relationships with radiosensitivity[J].Int J Radiat Oncol Biol Phys,1999,45 (1):1005-1010.
  • 8Kumar P,Gao Q,Ning Y,et al.Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone[J].Mol Cancer Ther,2008,7 (7):2060-2069.
  • 9Li Y,Qu X,Qu J,et al.Arsenic trioxide induces apoptosis and G/M phase arrest by inducing Cb1 to inhibit PI3K/Akt signaling and thereby regulate p53 activation[J].Cancer Lett,2009,284 (2):208-815.
  • 10Chiu HW,Lin JH,Chen YA,et al.Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis[J].Autophagy,2010,6 (3):353-365.

二级参考文献12

  • 1Peyromaure M, Debre B, Mao K, et al. Management of prostate cancer in China: a multicenter report of 6 institutions [ J]. J Urol,2005,174 (5) : 1794- 1797.
  • 2Kong D, Li Y, Wang Z, et al. Inhibition of angiogenesis and invasion by 3,3'-diindolyhnethane is mediated by the nuclear factor-KappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer [ J ]. Cancer Res, 2007, 67(7): 3310- 3319.
  • 3El-Gohary Y M, Sliverman J F, Olson P R, et al. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma[J]. Am J Clin Pathol, 2007, 127(4) : 572 -579.
  • 4Fukuda H, Tsuchiya N, Narita S, et al. Clinical implication of vascular endothelial growth factor T - 460C polymorphism in the risk and progression of prostate cancer[ J ]. Oncol Rep, 2007, 18 (5) : 1155 - 1163.
  • 5Lekas A, Lazaris A C, Deliveliotis C, et al. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue[ J]. Anticancer Res, 2006, 26(4B) : 2989 -2993.
  • 6Herszenyi L, Sipos F, Galamb O, et al. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon[J]. Pathol Oncol Res, 2008, 14(1) : 31 -37.
  • 7Chinni S R, Sivalogan S, Dong Z, et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells : the role of bone microenvironment-associated CXCL12 [ J]. Prostate, 2006, 66 (1) : 32 -48.
  • 8Chinni S R, Deng X, Dong Z, et al. The role of SDF-1alpha/CXCR4/ MMP-9 in prostate eaneer bone metastasis [ J]. Clin Exp Metastasis, 2002, 19(1) : 40 -52.
  • 9Uzzo R G, Crispen P L, Golovine K, et al. Diverse effects of zinc on NF-KappaB and AP-1 transcription factors: implications for prostate cancer progression[ J]. Carcinogenesis, 2006, 27(10) : 1980-1990.
  • 10Hao L, Zhang C, Qiu Y, et al. Recombination of CXCR4,VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer [ J]. Cancer Lett, 2007, 253 ( 1 ) : 34 - 42.

共引文献4

同被引文献31

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部